🔎 Trials Near Me

Akèy › Alòpesi Areat › Texas › San Antonio

Etid klinik pou Alòpesi Areat nan San Antonio, TX

6 etid pou Alòpesi Areat ap chèche patisipan nan sit nan ak bò kote San Antonio (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata

Ap rekriteFaz 3
  • Texas Dermatology and Laser Specialists /ID# 282813, San Antonio
Laj 6 a 17 · Tout sèks · Mizajou Oct 2, 2026 · NCT07772492

A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)

Ap rekriteFaz 2
  • Texas Dermatology and Laser Specialists - San Antonio - South New Braunfels Avenue, San Antonio
Laj 18 a 50 · Tout sèks · Mizajou Sep 22, 2026 · NCT07533006

A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata

Ap rekriteFaz 3
  • Texas Dermatology and Laser Specialists, San Antonio
Laj 12 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT07733765

A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata

Ap rekriteFaz 3
  • San Antonio Clinical Trials /ID# 284605, San Antonio
Laj 12 a 63 · Tout sèks · Mizajou Aug 3, 2026 · NCT06012240

A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.

Ap rekriteFaz 3
  • Texas Dermatology and Laser Specialists, San Antonio
Laj 6 a 14 · Tout sèks · Mizajou Apr 28, 2026 · NCT07029828

Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata

Ap rekriteFaz 3
  • Texas Dermatology And Laser Specialists, San Antonio
Laj 12 a 17 · Tout sèks · Mizajou Jan 28, 2026 · NCT07133308

Etid Alòpesi Areat nan lòt vil

Lòt etid nan San Antonio

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.